Newest Bard IVC Filter Failure Lawsuit Allegations Update: Resource4thePeople Urges Consumers to Review FDA, Research Study Findings about Adverse Events
San Diego, CA (PRWEB) August 19, 2013 -- http://www.resource4thepeople.com/defectivemedicaldevices/bard-ivc.html
Resource4thePeople announced today that it is encouraging consumers who may have allegations of serious side effects from C.R. Bard IVC filters and models from other manufacturers to familiarize themselves with government and scientific data about possible health risks.
For instance, C.R. Bard has posted the U.S. Food and Drug Administration warning to physicians and consumers about concerns raised by the agency in connection with the use of Inferior Vena Cava (IVC) filters on the company’s web site.*
Also posted on the site are the findings of medical researchers who conducted research into the safety and side effects of IVC filters, including those manufactured by Bard. One of the studies found that of 61 subjects who underwent a Bard G2 filter retrieval procedure, 15 adverse events occurred in patients, four of which were serious.
“Deep vein thrombosis and pulmonary embolisms are life-threatening medical conditions that have been attributed the use of IVC filters by the FDA in a health advisory citing the risk of adverse events with long-term use,” said Resource4thePeople. “The company acknowledges that by providing a link to the advisory.
“We are recommending that any consumers who had surgeries in which IVC filters were used familiarize themselves with the possible health consequences of these products. The FDA, for instance, cites nearly 1,000 adverse event reports in connection with these devices.”
Resource4thePeople also announced that its nationwide network of attorneys will continue its policy of offering free consultations to consumers who are seeking information about the legal rights they may have to seek compensation over serious side effects allegedly suffered as a result of IVC filters.
“We will also be continuing regular updates about the progress of litigation involving these allegations and any results from the investigation into these devices by the FDA or any new research findings in connection with their side effects,” said Resource4thePeople.
Resource4thePeople attorneys recently increased the number of C.R Bard and other IVC filters over which they are reviewing claims from consumers about allegations of serious side effects.
"Since our announcement of our expansion of the IVC filters under review we have received a larger volume of inquiries from consumers about allegations of heart problems and other serious side effects from IVC systems," said Resource4thePeople.
Among the models that are also being reviewed are the C.R. Bard Recovery IVC Filter and G2 IVC Filter, the Braun Tempofilter, the Cook Gunther Tulip and Select and the Rex Medical Option.
"If you are a consumer who had an IVC filter implant and suffered serious side effects and have any question about whether you are eligible to seek compensation we recommend that you contact our legal team as soon as possible to preserve all of your legal options," said Resource4thePeople.
The FDA’s Aug. 9, 2010 health advisory** warned physicians and consumers about concerns raised by the agency in connection with the use of IVC filters.
The side effects being investigated by Resource4thePeople attorneys include those outlined in the FDA health, such as lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.
Here is part of the FDA warning:
“Since 2005, the FDA has received 921 device adverse event reports involving IVC filters, of which 328 involved device migration, 146 involved embolizations (detachment of device components), 70 involved perforation of the IVC, and 56 involved filter fracture. Some of these events led to adverse clinical outcomes in patients. These types of events may be related to a retrievable filter remaining in the body for long periods of time, beyond the time when the risk of pulmonary embolism (PE) has subsided.
“The FDA is concerned that these retrievable IVC filters, intended for short-term placement, are not always removed once a patient’s risk for PE subsides. Known long term risks associated with IVC filters include but are not limited to lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.”
In researching court filings, Resource4thePeople notes the recent filing of a Bard IVC Filter lawsuit by a New York woman who is claiming in her lawsuit that the device was defectively designed, broke and caused her to suffer significant internal injuries.***
The woman is alleging the filter was implanted to prevent blood clots but broke apart with particles migrating through her body and damaging her internal organs.
“Resource4thePeople also notes that a respected medical group has responded**** to concerns about the safety of IVC filters.
A professional peer group medical review is being launched by The Society of Interventional Radiology and Society for Vascular Surgery, which announced Feb. 13, 2013 that it will form a task force to measure the health risk of IVC filters to patients.
IVC filters are medical devices designed to prevent blood clots in patients at risk for a pulmonary embolism in cases in which an anticoagulant is contraindicated or proven ineffective.
The FDA's health warning issued to health care professionals and consumers reports that serious health problems can occur on these spider-like devices when the legs that extend from it to block clots break off.
What can then occur, according to the FDA, is that these broken parts from the filter may travel to other parts of the body and cause serious problems such as lower limb deep vein thrombosis (DVT), filter fracture, filter migration, filter embolization and IVC perforation.
Sources:
**http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm221707.htm
***Case # 2:13-cv-2281, U.S. District Court, Eastern District of New York
****http://www.sirweb.org/news/newsPDF/Release_PRESERVE_Final_.pdf
Bill Callahan, iLawSuit, +1 (858) 602-2749, [email protected]
Share this article